The Role of 18F-FDG-PET in the Local/Regional Evaluation of Women with Breast Cancer
- 1 September 2002
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 75 (2) , 135-146
- https://doi.org/10.1023/a:1019664126220
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Positron Emission Tomography Using [18F]-Fluorodeoxy-d-Glucose to Predict the Pathologic Response of Breast Cancer to Primary ChemotherapyJournal of Clinical Oncology, 2000
- Positron Emission Tomography Using [18F]Fluorodeoxyglucose for Monitoring Primary Chemotherapy in Breast CancerJournal of Clinical Oncology, 2000
- Imaging of Axillary Lymph NodesActa Oncologica, 2000
- Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions.Journal of Clinical Oncology, 1998
- Diagnostic Value of Positron Emission Tomography for Detecting Breast CancerWorld Journal of Surgery, 1998
- Skeletal metastases from breast cancer: uptake of 18 F-fluoride measured with positron emission tomography in correlation with CTSkeletal Radiology, 1998
- Axillary lymph node metastases: screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET.Radiology, 1997
- Assessment of Axillary Lymph Node Involvement in Breast Cancer Patients With Positron Emission Tomography Using Radiolabeled 2-(Fluorine-18)-fluoro-2-deoxy-D-glucoseJNCI Journal of the National Cancer Institute, 1996
- Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET.Radiology, 1993
- The Application of Positron Emission Tomographie Imaging With Fluorodeoxyglucose to the Evaluation of Breast DiseaseAnnals of Surgery, 1992